Oracea (Doxycycline)

Doxycycline, the active ingredient in Oracea, is a tetracycline antibiotic presented as a 40 mg oral capsule for oral use. It is indicated for the treatment of inflammatory lesions of rosacea in adult patients. GNH USA supplies Oracea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oracea, a doxycycline‑based tetracycline, acts on the inflammatory pathway of rosacea. - Rosacea (papulopustular lesions): reduces the number and severity of papules and pustules on the face. - Rosacea (maintenance therapy): helps maintain clear skin after an initial treatment course. - Rosacea (adult patients): provides a targeted oral option for adults with persistent inflammatory lesions.

Common Side Effects: - Nausea: mild stomach upset may occur. - Diarrhea: loose stools are reported in some patients. - Photosensitivity: increased skin sensitivity to sunlight. - Esophageal irritation: discomfort when the capsule is not taken with enough water. - Vaginal candidiasis: occasional yeast infection.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hepatotoxicity: signs of liver injury such as jaundice. - Pseudotumor cerebri: persistent headache and visual changes. - Blood dyscrasias: unusual bruising or bleeding. - Intracranial hypertension: severe headache with visual disturbances.

Before starting Oracea, consider the following precautions: - Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional. - Breastfeeding: consult a physician as doxycycline may pass into breast milk. - Liver disease: dose adjustment may be required in hepatic impairment. - Renal impairment: monitor kidney function, especially in severe cases. - Concomitant photosensitizing agents: limit sun exposure and use protective clothing. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct light.

Oracea can interact with several medicines; monitor the following: Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Oral retinoids (e.g., isotretinoin): heightened intracranial hypertension risk. - Vitamin/mineral supplements containing iron, calcium, magnesium, or aluminum: markedly reduce doxycycline absorption.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., phenytoin): may lower doxycycline levels. - Oral contraceptives: reduced efficacy, consider backup contraception. - Barbiturates and rifampin: may increase hepatic metabolism of doxycycline.